Table 2.
Functional and pathway enrichment analysis of the common DEGs.
| Category | Term | Count | P value |
| GOTERM_BP_FAT | GO:0055114∼oxidation-reduction process | 41 | 5.26E-13 |
| GOTERM_BP_FAT | GO:0006082∼organic acid metabolic process | 38 | 4.31E-12 |
| GOTERM_BP_FAT | GO:0019752∼carboxylic acid metabolic process | 36 | 6.26E-12 |
| GOTERM_BP_FAT | GO:0043436∼oxoacid metabolic process | 36 | 7.41E-12 |
| GOTERM_BP_FAT | GO:0032787∼monocarboxylic acid metabolic process | 29 | 2.30E-11 |
| GOTERM_BP_FAT | GO:1901565∼organonitrogen compound catabolic process | 19 | 1.22E-07 |
| GOTERM_BP_FAT | GO:0008202∼steroid metabolic process | 16 | 4.69E-07 |
| GOTERM_BP_FAT | GO:0019373∼epoxygenase P450 pathway | 6 | 1.22E-06 |
| GOTERM_BP_FAT | GO:0040007∼growth | 29 | 1.47E-06 |
| GOTERM_BP_FAT | GO:0017144∼drug metabolic process | 7 | 2.15E-06 |
| GOTERM_CC_FAT | GO:0005615∼extracellular space | 44 | 1.16E-07 |
| GOTERM_CC_FAT | GO:0044421∼extracellular region part | 80 | 2.66E-06 |
| GOTERM_CC_FAT | GO:0005576∼extracellular region | 90 | 4.40E-06 |
| GOTERM_CC_FAT | GO:0045120∼pronucleus | 4 | 8.52E-04 |
| GOTERM_CC_FAT | GO:1903561∼extracellular vesicle | 55 | 0.001147 |
| GOTERM_CC_FAT | GO:0043230∼extracellular organelle | 55 | 0.001157 |
| GOTERM_CC_FAT | GO:1990777∼lipoprotein particle | 5 | 0.001538 |
| GOTERM_CC_FAT | GO:0034358∼plasma lipoprotein particle | 5 | 0.001538 |
| GOTERM_CC_FAT | GO:0005887∼integral component of plasma membrane | 36 | 0.001686 |
| GOTERM_CC_FAT | GO:0070062∼extracellular exosome | 54 | 0.001780 |
| GOTERM_MF_FAT | GO:0004497∼monooxygenase activity | 15 | 1.39E-11 |
| GOTERM_MF_FAT | GO:0016705∼oxidoreductase activity | 16 | 9.28E-10 |
| GOTERM_MF_FAT | GO:0020037∼heme binding | 14 | 7.03E-09 |
| GOTERM_MF_FAT | GO:0005506∼iron ion binding | 15 | 1.06E-08 |
| GOTERM_MF_FAT | GO:0046906∼tetrapyrrole binding | 14 | 1.52E-08 |
| GOTERM_MF_FAT | GO:0019825∼oxygen binding | 8 | 1.68E-06 |
| GOTERM_MF_FAT | GO:0048037∼cofactor binding | 14 | 1.88E-05 |
| GOTERM_MF_FAT | GO:0016614∼oxidoreductase activity | 10 | 3.18E-05 |
| GOTERM_MF_FAT | GO:0008395∼steroid hydroxylase activity | 6 | 3.67E-05 |
| GOTERM_MF_FAT | GO:0016709∼oxidoreductase activity | 6 | 1.35E-04 |
| KEGG_PATHWAY | hsa01100:Metabolic pathways | 34 | 1.49E-04 |
| KEGG_PATHWAY | hsa00380:Tryptophan metabolism | 6 | 2.58E-04 |
| KEGG_PATHWAY | hsa05204:Chemical carcinogenesis | 7 | 0.001024 |
| KEGG_PATHWAY | hsa00232:Caffeine metabolism | 3 | 0.002033 |
| KEGG_PATHWAY | hsa00830:Retinol metabolism | 6 | 0.002271 |
| KEGG_PATHWAY | hsa00982:Drug metabolism – cytochrome P450 | 6 | 0.002967 |
| KEGG_PATHWAY | hsa00591:Linoleic acid metabolism | 4 | 0.008281 |
| KEGG_PATHWAY | hsa00590:Arachidonic acid metabolism | 5 | 0.011650 |
| KEGG_PATHWAY | hsa01130:Biosynthesis of antibiotics | 9 | 0.011704 |
| KEGG_PATHWAY | hsa04115:p53 signaling pathway | 5 | 0.016021 |
DEGs = differentially expressed genes, GO = Gene Ontology, KEGG = Kyoto encyclopedia of genes and genomes.